These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 35501642)

  • 41. T cell counts and IL-6 concentration in blood of North African COVID-19 patients are two independent prognostic factors for severe disease and death.
    Belaid B; Lamara Mahammad L; Mihi B; Rahali SY; Djidjeli A; Larab Z; Berkani L; Berkane I; Sayah W; Merah F; Lazli NZ; Kheddouci L; Kadi A; Ouali M; Khellafi R; Mekideche D; Kheliouen A; Ayoub S; Hamidi RM; Derrar F; Gharnaout M; Allam I; Djidjik R
    J Leukoc Biol; 2022 Jan; 111(1):269-281. PubMed ID: 33527487
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Immunophenotyping of lymphocytes and monocytes and the status of cytokines in the clinical course of Covid-19 patients.
    Idiz UO; Yurttas TT; Degirmencioglu S; Orhan B; Erdogan E; Sevik H; Sevinc MM
    J Med Virol; 2022 Oct; 94(10):4744-4753. PubMed ID: 35667877
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Increased CD95 (Fas) and PD-1 expression in peripheral blood T lymphocytes in COVID-19 patients.
    Bellesi S; Metafuni E; Hohaus S; Maiolo E; Marchionni F; D'Innocenzo S; La Sorda M; Ferraironi M; Ramundo F; Fantoni M; Murri R; Cingolani A; Sica S; Gasbarrini A; Sanguinetti M; Chiusolo P; De Stefano V
    Br J Haematol; 2020 Oct; 191(2):207-211. PubMed ID: 32679621
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Lymphocyte Subset Alteration and Monocyte CD4 Expression Reduction in Patients with Severe COVID-19.
    Kazancioglu S; Yilmaz FM; Bastug A; Sakallı A; Ozbay BO; Buyuktarakci C; Bodur H; Yilmaz G
    Viral Immunol; 2021 Jun; 34(5):342-351. PubMed ID: 33264073
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Decreased absolute counts of T lymphocyte subsets and their relation to disease in squamous cell carcinoma of the head and neck.
    Kuss I; Hathaway B; Ferris RL; Gooding W; Whiteside TL
    Clin Cancer Res; 2004 Jun; 10(11):3755-62. PubMed ID: 15173082
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Changes of lymphocyte subsets in peripheral blood of patients with hepatitis C].
    Wan H; Li Y; Yang N; Yuan W; Xie N; Wang D; Guo T; Mao Y
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2014 Oct; 30(10):1058-61. PubMed ID: 25270208
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The informative value of CD3+CD4+ and CD3+CD8+ T-cell count and cHIS scale as predictors of severe COVID-19 when using interleukin-6 receptor blockers in the in-hospital setting.
    Kruglova TS; Fomina DS
    Ter Arkh; 2022 Dec; 94(11):1294-1302. PubMed ID: 37167168
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The characteristics and predictive role of lymphocyte subsets in COVID-19 patients.
    Zhang W; Li L; Liu J; Chen L; Zhou F; Jin T; Jiang L; Li X; Yang M; Wang H
    Int J Infect Dis; 2020 Oct; 99():92-99. PubMed ID: 32758688
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Effect of Pembrolizumab on T Lymphocyte Subsets in Patients with Advanced 
Non-small Cell Lung Cancer and Its Therapeutic Effect].
    Wang Y; Wang Y; Jiang M; Zhao Y; Zhang X
    Zhongguo Fei Ai Za Zhi; 2021 Mar; 24(3):182-187. PubMed ID: 33819968
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Apoptosis and immunophenotyping of peripheral blood lymphocytes in Iranian COVID-19 patients: Clinical and laboratory characteristics.
    Taghiloo S; Aliyali M; Abedi S; Mehravaran H; Sharifpour A; Zaboli E; Eslami-Jouybari M; Ghasemian R; Vahedi-Larijani L; Hossein-Nattaj H; Amjadi O; Rezazadeh H; Ajami A; Asgarian-Omran H
    J Med Virol; 2021 Mar; 93(3):1589-1598. PubMed ID: 32910458
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Poor Survival in COVID-19 Associated with Lymphopenia and Higher Neutrophile-Lymphocyte Ratio.
    Montiel-Cervantes LA; Medina G; Pilar Cruz-Domínguez M; Pérez-Tapia SM; Jiménez-Martínez MC; Arrieta-Oliva HI; Carballo-Uicab G; López-Pelcastre L; Camacho-Sandoval R
    Isr Med Assoc J; 2021 Mar; 23(3):153-159. PubMed ID: 33734627
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Association of lymphocyte subsets with mortality in severe COVID-19 pneumonia patients.
    Ashrafi F; Nematollahi P; Salmasi M; Hedayat A; Amra B
    J Clin Lab Anal; 2021 Nov; 35(11):e24046. PubMed ID: 34626490
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Reference range of naïve T and T memory lymphocyte subsets in peripheral blood of healthy adult.
    Xia Y; Liu A; Li W; Liu Y; Zhang G; Ye S; Zhao Z; Shi J; Jia Y; Liu X; Guo Y; Chen H; Yu J
    Clin Exp Immunol; 2022 Apr; 207(2):208-217. PubMed ID: 35020890
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Lymphocyte subset alterations with disease severity, imaging manifestation, and delayed hospitalization in COVID-19 patients.
    Wu D; Wu X; Huang J; Rao Q; Zhang Q; Zhang W
    BMC Infect Dis; 2021 Jul; 21(1):631. PubMed ID: 34210280
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Therapeutic and prognostic implications of peripheral blood lymphopenia in patients with Hodgkin's disease.
    Ayoub JP; Palmer JL; Huh Y; Cabanillas F; Younes A
    Leuk Lymphoma; 1999 Aug; 34(5-6):519-27. PubMed ID: 10492075
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Fine Analysis of Lymphocyte Subpopulations in SARS-CoV-2 Infected Patients: Differential Profiling of Patients With Severe Outcome.
    Clavarino G; Leroy C; Epaulard O; Raskovalova T; Vilotitch A; Pernollet M; Dumestre-Pérard C; Defendi F; Le Maréchal M; Le Gouellec A; Audoin P; Bosson JL; Poignard P; Roustit M; Jacob MC; Cesbron JY
    Front Immunol; 2022; 13():889813. PubMed ID: 35911748
    [TBL] [Abstract][Full Text] [Related]  

  • 57. T-lymphocyte populations in hepatitis C and HIV co-infected patients treated with interferon-alfa-2a and ribavirin.
    Neau D; Galpérine T; Legrand E; Pitard V; Neau-Cransac M; Moreau JF; Ragnaud JM; Dupon M; Fleury H; Lafon ME
    HIV Med; 2003 Apr; 4(2):120-6. PubMed ID: 12702132
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Change of T lymphocyte and its activated subsets in SARS patients].
    Yu XY; Zhang YC; Han CW; Wang P; Xue XJ; Cong YL
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2003 Oct; 25(5):542-6. PubMed ID: 14650154
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Expression of lymphocytes and lymphocyte subsets in patients with severe acute respiratory syndrome.
    Cui W; Fan Y; Wu W; Zhang F; Wang JY; Ni AP
    Clin Infect Dis; 2003 Sep; 37(6):857-9. PubMed ID: 12955652
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Risk Factors for Mortality of COVID-19 Patient Based on Clinical Course: A Single Center Retrospective Case-Control Study.
    Zhang J; Wang Z; Wang X; Hu Z; Yang C; Lei P
    Front Immunol; 2021; 12():581469. PubMed ID: 33664741
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.